C-WKDFgene/enzyme therapy, damage repair, ageing biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Remove or repair age-associated intracellular 7-ketocholesterol accumulation implicated in disease and ageing.
Gene or enzyme therapy aimed at removing 7-ketocholesterol.
Listed in the company pipeline as a gene/enzyme therapy aimed at removing 7-ketocholesterol.
Provide sequencing analysis, mitochondrial diagnostics, mtDNA fragility prediction, haplogroup reconstruction, and mutational spectra reconstruction.
Bioinformatics services for sequencing analysis and mitochondrial genome interpretation.
Described as an offered company service in the supplied site analysis.
Remove or repair age-associated intracellular lipofuscin accumulation as part of damage-repair bioengineering for ageing and age-related degeneration.
Gene or enzyme therapy aimed at degrading or clearing intracellular lipofuscin.
Listed in the company pipeline as a gene/enzyme therapy aimed at removing lipofuscin.
Develop a comprehensive panel of primary ageing biomarkers for assessing ageing-related biological state or damage.
Biomarker panel development; specific assays are not disclosed in the supplied material.
Listed in the company pipeline as a comprehensive panel of primary ageing biomarkers.